Stock BONEX BONESUPPORT HOLDING AB
Add to a list
To use this feature you must be a member
Log inSign up

Company Bonesupport Holding AB

Equities

BONEX

SE0009858152

Pharmaceuticals

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:52 2024-04-23 am EDT 		5-day change 1st Jan Change
244 SEK -0.81% Intraday chart for Bonesupport Holding AB +1.16% +29.65%
Mar. 15 Nordic Shares Decreased Friday; BoneSupport Holding Posted Biggest Loss DJ
Mar. 14 Nordic Stocks Moved Upward Thursday; Scatec Climbed Highest DJ

Business Summary

Bonesupport Holding AB is a Sweden-based orthobiologics company. It develops and commercialize injectable bioceramic bone graft substitutes which remodel to host bone and have the capability to elute drugs directly into the bone void. The marketed synthetic bone graft substitutes are CERAMENT BVF, CERAMENT G and CERAMENT V, which are based on the CERAMENT technology platform. The products are commercially available in Europe and the United States, as well as in India, Malaysia, Oman and Singapore. The products are developed to treat patients with fractures and bone voids caused by trauma and related surgery, as well as caused by infection or diseases, such as chronic osteomyelitis, revision arthroplasty and infected diabetic foot.

Number of employees: 110

Sales per Business

SEK in Million2022Weight2023Weight Delta
Cerament Gentamicin and Ceramanent Vancomycin
60.6 %
112 34.1 % 358 60.6 % +219.37%
Cerament Bone Void Filler
37.7 %
210 63.9 % 223 37.7 % +6.11%
Other
1.6 %
6 1.9 % 10 1.6 % +52.14%

Sales per region

SEK in Million2022Weight2023Weight Delta
North America
74.9 %
217 66.0 % 442 74.9 % +104.01%
United Kingdom
12.4 %
49 14.8 % 73 12.4 % +51.03%
Europe and Rest of the World
10.8 %
54 16.3 % 64 10.8 % +18.62%
Sweden
2.0 %
10 2.9 % 12 2.0 % +19.59%

Managers

Managers TitleAgeSince
Emil Billbäck CEO
 Chief Executive Officer 54 18-02-28
Hakan Johansson DFI
 Director of Finance/CFO 61 18-10-31
Michael Mortensen COO
 Chief Operating Officer - 21-11-30
Michael Diefenbeck CTO
 Chief Tech/Sci/R&D Officer 50 17-03-31
Annelie Vikner IRO
 Public Communications Contact 53 19-02-28
Michael Roth PRN
 Corporate Officer/Principal - 20-05-31
Kristina Ingvar LAW
 General Counsel 52 20-01-31
Helena Brandt HRO
 Human Resources Officer 59 17-10-15
Linda Butcher PRN
 Corporate Officer/Principal 61 09-12-31
Fergus MacLeod PRN
 Corporate Officer/Principal 54 19-11-17

Members of the board

Members of the board TitleAgeSince
Björn Ingemar Odlander BRD
 Director/Board Member 66 -
Erling Lennart Johansson CHM
 Chairman 69 17-02-28
Sven Håkan Björklund BRD
 Director/Board Member 68 16-08-31
Mary O'Connor BRD
 Director/Board Member - -
Christine Rankin BRD
 Director/Board Member 60 22-04-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 1,142,060 0 0 89.77 %
Stock B 1 65,055,575 59,425,845 ( 91.35 %) 0

Shareholders

NameEquities%Valuation
HealthCap AB
10.15 %
6,602,360 10.15 % 141 M kr
Swedbank Robur Fonder AB
9.787 %
6,366,836 9.787 % 136 M kr
Capital Research & Management Co. (World Investors)
5.374 %
3,495,961 5.374 % 75 M kr
Fjärde AP-fonden
4.563 %
2,968,195 4.563 % 63 M kr
Lancelot Asset Management AB
3.666 %
2,385,000 3.666 % 51 M kr
Tredje AP-fonden
3.459 %
2,250,000 3.459 % 48 M kr
Norges Bank Investment Management
2.780 %
1,808,781 2.780 % 39 M kr
Andra AP-fonden
2.222 %
1,445,275 2.222 % 31 M kr
Didner & Gerge Fonder AB
1.640 %
1,067,087 1.640 % 23 M kr
Cliens Kapitalförvaltning AB
1.153 %
750,000 1.153 % 16 M kr
NameEquities%Valuation
BONESUPPORT HOLDING AB
100.00 %
1,642,438 100.00 % 35 M kr

Holdings

NameEquities%Valuation
BONESUPPORT HOLDING AB
100.00%
 1,642,438 100.00% 35,021,968 $

Company contact information

BONESUPPORT HOLDING AB

Scheelevägen 19

223 70, Lund

+46 4 62 86 53 70

http://www.bonesupport.com
address Bonesupport Holding AB(BONEX)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Ratings for Bonesupport Holding AB

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
244 SEK
Average target price
292.7 SEK
Spread / Average Target
+19.95%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
BONESUPPORT HOLDING AB Stock Bonesupport Holding AB
+29.65% 1.48B
CSL LIMITED Stock CSL Limited
-2.68% 85.68B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+4.08% 41.4B
BIOGEN INC. Stock Biogen Inc.
-25.35% 28.22B
UCB Stock UCB
+54.31% 24.64B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-4.52% 16.98B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-42.09% 13.29B
INCYTE CORPORATION Stock Incyte Corporation
-17.77% 11.66B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-12.10% 11.65B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+0.75% 8.18B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. BONEX Stock
  4. Company Bonesupport Holding AB